levothyroxine

(redirected from Levothroid)
Also found in: Dictionary.
Related to Levothroid: Levothyroxine, Synthroid

levothyroxine

 [le″vo-thi-rok´sin]
l-thyroxine, obtained from the thyroid gland of domesticated food animals or prepared synthetically; used for replacement therapy in hypothyroidism and for the prophylaxis and treatment of goiter and of thyroid cancer; administered orally, intravenously, or intramuscularly as the sodium salt.

levothyroxine

/le·vo·thy·rox·ine/ (le″vo-thi-rok´sēn) -thyroxine, obtained from the thyroid gland of domesticated food animals or prepared synthetically; used as the sodium salt in the treatment of hypothyroidism and the treatment and prophylaxis of goiter and thyroid carcinoma.

levothyroxine

(lē′və-thī-rŏk′sēn′, -sĭn)
n.
An isomer of thyroxine, C15H10I4NO4, used in the form of its sodium salt to treat thyroxine deficiency.

levothyroxine

Thyroid hormone as a sodium salt used to treat hypothyroidism. The drug is on the WHO official list. A brand name is Thyronine.

levothyroxine

the pharmaceutical name for the thyroid hormone thyroxine (T4); used for replacement therapy in hypothyroidism.
References in periodicals archive ?
1) In addition to manufacturing Armour Thyroid, Forest makes Levothroid, a proprietary brand of levothyroxine (synthetic thyroxine, or T4).
Food and Drug Administration (FDA): Unithroid, Levoxyl, Synthroid, Levothroid, Levolet, Levo-T, and Novothyrox (only the first four are currently being marketed in the US).
Separately, Forest distributes Levothroid, a synthetic levothyroxine product for the treatment of hypothyroidism, pursuant to a distribution agreement with the product's manufacturer and holder of the product's NDA.
Pending further details Forest has discontinued shipping Levothroid to its customers and does not know how long the product will be unavailable.
entered into a global settlement in September 2010, as part of which the company, among other things, pleaded guilty in November 2010 to two strict liability, no-intent misdemeanor violations of the federal Food, Drug and Cosmetic Act, relating to conduct that occurred almost a decade ago involving the distribution and marketing of Levothroid and Celexa.
Lannett: Food and Drug Administration (FDA) Warns Forest Laboratories Of the Marketing of Levothroid
Other drugs contributing to top line growth include Tiazac, Aerochamber and Levothroid.
Other drugs contributing to top-line growth include Tiazac, increasing 25 percent, Thyroid increasing 14 percent, and Levothroid, increasing 71 percent.
New prescription growth for AeroBid, our metered dose inhaler for the treatment of asthma, has continued to accelerate and we are also benefiting from excellent prescription growth for Levothroid, our thyroid replacement product which we acquired and began to promote this past year.